LCS101 protection from Chemotherapy side effects

The protective properties of LCS101 were tested in a randomized, controlled, double blind clinical trial that was conducted on breast cancer patients at the Sourasky (Ichilov) Medical Center, in Tel-Aviv, Israel. All patients had been diagnosed with localized tumors and referred to chemotherapy before they were included in the study.

The patients were randomized to receive either chemotherapy with LCS101 or chemotherapy with a placebo.

The interventions (LCS101 or Placebo) were started two weeks prior to the first chemotherapy dose and continued until the last dose. Neither the patients nor the medical staff were aware of who was on the placebo and who was on LCS101, following the double-blind protocol.

This study focused on the rates of anemia and leukopenia, and showed that 82% of patients who took LCS101 did not suffer from a decrease of white blood cells (WBC) or red blood cells (RBC) counts.

Publisher:  The Oncologist Journal
Click here for the full publication. 

An additional clinical trial tested the effect of LCS101 on chemotherapy side-effects in breast cancer patients.

89% of the patients reported LCS101 improved their quality of life and helped reduce their symptoms such as fatigue, weakness, pain, nausea, vomiting and decreased appetite.

Publisher: Integrative Medicine Insights Journal
Click here for the full publication. 

LCS101 Anti-Cancer effect

The selective killing effect of LCS101 was tested in pre-clinical trials (in vitro).

The aim of the study was to examine the selectivity of the effects of the compound, alone and in conjunction with conventional chemotherapy agents, on cancer cells.

The study demonstrated that the formula actively destroys breast, colon and prostate cancer cell lines. The formula was also shown to protect normal cells from the damages associated with chemotherapy, and potentiating the cancer cells to the treatment.

Publisher: International Journal of Oncology
Click here for the full publication. 

LCS101 Immunological effect

The effect of LCS101 on various components of the immune system was evaluated in a pre-clinical trial. The study focused on the potential role of LCS101 in immune system stimulation.

The results suggest that LCS101 has an immune-modulating capacity – as evidenced by improvement in both adaptive and innate immunity.

Publisher: OncoTargets and Therapy
Click here for the full publication. 

LCS101 interaction with chemotherapy

The research included pre-clinical studies conducted with a chemotherapy testing dose and time dependent interaction with on over 10 different type of cancers and 10 different types of chemotherapy.

The findings of the study showed that the botanical formula LCS101 does not reduce the cytotoxic effects of multiple chemotherapy agents. Instead, the addition of LCS101 led to increased death of cancer cells from the chemotherapy agents.

Publisher: Journal of Cancer Science & Therapy
Click here for the full publication. 

LCS101 effect on anti cancer effect of Radiation therapy

This pre-clinical study examined the interaction between LCS101 and radiation therapy on cancer cell lines where incremental doses of LCS101 were added to 5 types of cell lines 4 hours after single-dose of radiation.

The addition of the botanical formula LCS101 to irradiated cancer cells results in an apparent additive effect, most likely through a ROS-mediated mechanism. These findings support the use of LCS101 by patients undergoing radiation therapy, for both its clinical as well as anti-cancer effects.

Publisher: Journal of Cancer Research and Clinical Oncology
Click here for the full publication. 

Botanical Formula LCS101: A Multi-Targeted Approach to Cancer Care

Published at: Integrative Cancer Therapies Journal

Effect of the botanical formula LCS101 on the anti-cancer effects of radiation therapy

Published at: Journal of Cancer Research and Clinical Oncology

Effect of the Botanical Compound LCS101 on Cytotoxicity of Chemotherapy

Published at: Journal of Cancer Science & Therapy

Selective anticancer effects and protection from chemotherapy by the botanical compound LCS101: Implications for cancer treatment

Published at: International Journal of Oncology

A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Published at:  The Oncologist Journal

Effect of the Botanical Compound LCS101 on Chemotherapy-Induced Symptoms in Patients with Breast Cancer: A Case Series Report

Published at: Integrative Medicine Insights Journal

Clinical Roundup: Selected Treatment Options for Chemotherapy-Induced Nausea and Vomiting

Published at: Alternative and Complementary Therapies Journal

Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment

Published at: OncoTargets and Therapy

Effect of Chinese Herbal Therapy on Breast Cancer Adenocarcinoma Cell Lines

Published at: The Journal of International Medical Research

Effect of the botanical compound LCS102 on innate immunity

Published at: The Biomedical Reports Medical Journal

A table of the 14 botanical ingredients  of the formula LCS101 with scientific references for their effect:

References

1. Sun JY, Yang H, Miao S, Li JP, Wang SW, Zhu MZ, Xie YH, Wang JB, Liu Z, Yang Q: Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo. Phytomedicine 2009, 16(11):1070-1074.
2. Cho WC, Leung KN: In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 2007, 252(1):43-54.
3. Brush J, Mendenhall E, Guggenheim A, Chan T, Connelly E, Soumyanath A, Buresh R, Barrett R, Zwickey H: The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans. Phytother Res 2006, 20(8):687-695.
4. Sun Y, Hersh EM, Talpaz M, Lee SL, Wong W, Loo TL, Mavligit GM: Immune restoration and/or augmentation of local graft versus host reaction by traditional Chinese medicinal herbs. Cancer 1983, 52(1):70-73.
5. Zhao KS, Mancini C, Doria G: Enhancement of the immune response in mice by Astragalus membranaceus extracts. Immunopharmacology 1990, 20(3):225-233.
6. Cho WC, Leung KN: In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 2007, 113(1):132-141.
7. Rittenhouse JR, Lui PD, Lau BH: Chinese medicinal herbs reverse macrophage suppression induced by urological tumors. J Urol 1991, 146(2):486-490.
8. Xu HD, You CG, Zhang RL, Gao P, Wang ZR: Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis by macrophages. J Int Med Res 2007, 35(1):84-90.
9. Yoshida Y, Wang MQ, Liu JN, Shan BE, Yamashita U: Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol 1997, 19(7):359-370.
10. Chu DT, Lepe-Zuniga J, Wong WL, LaPushin R, Mavligit GM: Fractionated extract of Astragalus membranaceus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2. J Clin Lab Immunol 1988, 26(4):183-187.
11. Wang Y, Qian XJ, Hadley HR, Lau BH: Phytochemicals potentiate interleukin-2 generated lymphokine-activated killer cell cytotoxicity against murine renal cell carcinoma. Mol Biother 1992, 4(3):143-146.
12. Clement-Kruzel S, Hwang SA, Kruzel MC, Dasgupta A, Actor JK: Immune modulation of macrophage pro-inflammatory response by goldenseal and Astragalus extracts. J Med Food 2008, 11(3):493-498.
13. Ryu M, Kim EH, Chun M, Kang S, Shim B, Yu YB, Jeong G, Lee JS: Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J Ethnopharmacol 2008, 115(2):184-193.
14. Zhu XL, Zhu BD: Mechanisms by which Astragalus membranaceus injection regulates hematopoiesis in myelosuppressed mice. Phytother Res 2007, 21(7):663-667.
15. Chu DT, Wong WL, Mavligit GM: Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 1988, 25(3):125-129.
16. Chu DT, Wong WL, Mavligit GM: Immunotherapy with Chinese medicinal herbs. I. Immune restoration of local xenogeneic graft-versus-host reaction in cancer patients by fractionated Astragalus membranaceus in vitro. J Clin Lab Immunol 1988, 25(3):119-123.
17. Luo Z, Zhong L, Han X, Wang H, Zhong J, Xuan Z: Astragalus membranaceus prevents daunorubicin-induced apoptosis of cultured neonatal cardiomyocytes: role of free radical effect of Astragalus membranaceus on daunorubicin cardiotoxicity. Phytother Res 2009, 23(6):761-767.
18. Li Y, Liu X, Xue SZ: Antidotal effect of glucoside extracted from Astragalus membranaceus on dimethoate intoxication in guinea pigs. Med Lav 1998, 89 Suppl 2:S136-141.
19. Zhang L, Yang Y, Wang Y, Gao X: Astragalus membranaceus extract promotes neovascularisation by VEGF pathway in rat model of ischemic injury. Pharmazie, 66(2):144-1.
20. Cui R, He J, Wang B, Zhang F, Chen G, Yin S, Shen H: Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol 2003, 51(1):75-80.
21. Sheng BW, Chen XF, Zhao J, He DL, Nan XY: Astragalus membranaceus reduces free radical-mediated injury to renal tubules in rabbits receiving high-energy shock waves. Chin Med J (Engl) 2005, 118(1):43-49.
22. Wong BY, Lau BH, Tadi PP, Teel RW: Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of aflatoxin B1. Mutat Res 1992, 279(3):209-216.
23. Huang HL, Chen CC, Yeh CY, Huang RL: Reactive oxygen species mediation of baizhu-induced apoptosis in human leukemia cells. J Ethnopharmacol 2005, 97(1):21-29.
24. Kim SH, Jung HN, Lee KY, Kim J, Lee JC, Jang YS: Suppression of Th2-type immune response-mediated allergic diarrhea following oral administration of traditional Korean medicine: Atractylodes macrocephala Koidz. Immunopharmacol Immunotoxicol 2005, 27(2):331-343.
25. Kang SA, Park HJ, Kim MJ, Lee SY, Han SW, Leem KH: Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J Ethnopharmacol 2005, 97(2):231-235.
26. Kim MJ, Park HJ, Hong MS, Park HJ, Kim MS, Leem KH, Kim JB, Kim YJ, Kim HK: Citrus Reticulata blanco induces apoptosis in human gastric cancer cells SNU-668. Nutr Cancer 2005, 51(1):78-82.
27. Ho SC, Lin CC: Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels. J Agric Food Chem 2008, 56(17):7976-7982.
28. Jung KH, Ha E, Kim MJ, Won HJ, Zheng LT, Kim HK, Hong SJ, Chung JH, Yim SV: Suppressive effects of nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression by Citrus reticulata extract in RAW 264.7 macrophage cells. Food Chem Toxicol 2007, 45(8):1545-15.
29. Zhou XM, Huang MM, He CC, Li JX: Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. J Ethnopharmacol 2009, 126(1):143-148.
30. Xu GH, Chen JC, Liu DH, Zhang YH, Jiang P, Ye XQ: Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water. J Food Sci 2008, 73(1):C11-18.
31. Xu RH, Peng XE, Chen GZ, Chen GL: Effects of cordyceps sinensis on natural killer activity and colony formation of B16 melanoma. Chin Med J (Engl) 1992, 105(2):97-101.
32. Yoon T, Cheon MS, Lee AY, Lee do Y, Moon BC, Chun JM, Choo BK, Kim HK: Anti-inflammatory activity of methylene chloride fraction from Glehnia littoralis extract via suppression of NF-kappa B and mitogen-activated protein kinase activity. J Pharmacol Sci 2010, 112(1):46-55.
33. Yoon T, Lee do Y, Lee AY, Choi G, Choo BK, Kim HK: Anti-inflammatory effects of Glehnia littoralis extract in acute and chronic cutaneous inflammation. Immunopharmacol Immunotoxicol 2010, 32(4):663-670.
34. Jeong JC, Kim JW, Kwon CH, Kim TH, Kim YK: Fructus ligustri lucidi extracts induce human glioma cell death through regulation of Akt/mTOR pathway in vitro and reduce glioma tumor growth in U87MG xenograft mouse model. Phytother Res 2011, 25(3):429-434.
35. An HJ, Jeong HJ, Um JY, Park YJ, Park RK, Kim EC, Na HJ, Shin TY, Kim HM, Hong SH: Fructus Ligustrum lucidi inhibits inflammatory mediator release through inhibition of nuclear factor-kappaB in mouse peritoneal macrophages. J Pharm Pharmacol 2007, 59(9):1279-1285.
36. Ha KT, Yoon SJ, Choi DY, Kim DW, Kim JK, Kim CH: Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol 2005, 96(3):529-535.
37. Zhang R, Kang KA, Piao MJ, Kim KC, Kim AD, Chae S, Park JS, Youn UJ, Hyun JW: Cytoprotective effect of the fruits of Lycium chinense Miller against oxidative stress-induced hepatotoxicity. J Ethnopharmacol 2010, 130(2):299-306.
38. Hsu HY, Yang JJ, Ho YH, Lin CC: Difference in the effects of radioprotection between aerial and root parts of Lycium chinense. J Ethnopharmacol 1999, 64(2):101-108.
39. Hsu CC, Hsu CL, Tsai SE, Fu TY, Yen GC: Protective effect of Millettia reticulata Benth against CCl(4)-induced hepatic damage and inflammatory action in rats. J Med Food 2009, 12(4):821-828.
40. Gupta S, Zhang D, Yi J, Shao J: Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother 2004, 4(1):21-33.
41. Wong BY, Lau BH, Jia TY, Wan CP: Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer Biother Radiopharm 1996, 11(1):51-56.
42. Shan BE, Yoshida Y, Sugiura T, Yamashita U: Stimulating activity of Chinese medicinal herbs on human lymphocytes in vitro. Int J Immunopharmacol 1999, 21(3):149-159.
43. Kim SJ, Chung WS, Kim SS, Ko SG, Um JY: Antiinflammatory effect of Oldenlandia diffusa and its constituent, hentriacontane, through suppression of caspase-1 activation in mouse peritoneal macrophages. Phytother Res 2011, 25(10):1537-1546.
44. Chung HS, Jeong HJ, Hong SH, Kim MS, Kim SJ, Song BK, Jeong IS, Lee EJ, Ahn JW, Baek SH et al: Induction of nitric oxide synthase by Oldenlandia diffusa in mouse peritoneal macrophages. Biol Pharm Bull 2002, 25(9):1142-1146.
45. Wong BY, Lau BH, Teel RW: Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of benzo[a]pyrene 7,8-dihydrodiol and benzo[a]pyrene 7,8-dihydrodiol-9,10-epoxide. Cancer Lett 1992, 62(2):123-131.
46. Wong BY, Lau BH, Yamasaki T, Teel RW: Inhibition of dexamethasone-induced cytochrome P4-mediated mutagenicity and metabolism of aflatoxin B1 by Chinese medicinal herbs. Eur J Cancer Prev 1993, 2(4):351-356.
47. Song YH, Jeong SJ, Kwon HY, Kim B, Kim SH, Yoo DY: Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells. Biol Pharm Bull, 35(7):1022-1028.
48. Kou J, Sun Y, Lin Y, Cheng Z, Zheng W, Yu B, Xu Q: Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents. Biol Pharm Bull 2005, 28(7):1234-1238.
49. David Winston, Steven Maimes : book Adaptogens: Herbs for Strength, Stamina, and Stress Relief .Bear & Co, Mar 22, 2007
. Wang Y, Yan T, Shen J, Guo H, Xiang X: Preventive effect of Ophiopogon japonicus polysaccharides on an autoallergic mouse model for Sjogren’s syndrome by regulating the Th1/Th2 cytokine imbalance. J Ethnopharmacol 2007, 114(2):246-253.
51. Ou TT, Wu CH, Hsu JD, Chyau CC, Lee HJ, Wang CJ: Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo. J Ethnopharmacol 2011, 135(1):162-172.
52. Fuchs SM, Heinemann C, Schliemann-Willers S, Hartl H, Fluhr JW, Elsner P: Assessment of anti-inflammatory activity of Poria cocos in sodium lauryl sulphate-induced irritant contact dermatitis. Skin Res Technol 2006, 12(4):223-227.
53. Giner-Larza EM, Manez S, Giner-Pons RM, Carmen Recio M, Rios JL: On the anti-inflammatory and anti-phospholipase A(2) activity of extracts from lanostane-rich species. J Ethnopharmacol 2000, 73(1-2):61-69.
54. Yu SJ, Tseng J: Fu-Ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int J Immunopharmacol 1996, 18(1):37-44.
55. Feng L, Jia X, Zhu M, Chen Y, Shi F: Chemoprevention by Prunella vulgaris L. extract of non-small cell lung cancer via promoting apoptosis and regulating the cell cycle. Asian Pac J Cancer Prev 2010, 11(5):1355-1358.
56. Feng L, Jia XB, Jiang J, Zhu MM, Chen Y, Tan XB, Shi F: Combination of active components enhances the efficacy of Prunella in prevention and treatment of lung cancer. Molecules 2010, 15(11):7893-7906.
57. Choi JH, Han EH, Hwang YP, Choi JM, Choi CY, Chung YC, Seo JK, Jeong HG: Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression. Food Chem Toxicol 2010, 48(2):564-571.
58. Huang N, Hauck C, Yum MY, Rizshsky L, Widrlechner MP, McCoy JA, Murphy PA, Dixon PM, Nikolau BJ, Birt DF: Rosmarinic acid in Prunella vulgaris ethanol extract inhibits lipopolysaccharide-induced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophages. J Agric Food Chem 2009, 57(22):10579-10589.
59. Zdarilova A, Svobodova A, Simanek V, Ulrichova J: Prunella vulgaris extract and rosmarinic acid suppress lipopolysaccharide-induced alteration in human gingival fibroblasts. Toxicol In Vitro 2009, 23(3):386-392.
60. Han EH, Choi JH, Hwang YP, Park HJ, Choi CY, Chung YC, Seo JK, Jeong HG: Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris. Food Chem Toxicol 2009, 47(1):62-69.
61. Fong S, Shoemaker M, Cadaoas J, Lo A, Liao W, Tagliaferri M, Cohen I, Shtivelman E: Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biol Ther 2008, 7(4):577-586.
62. Klawitter J, Klawitter J, Gurshtein J, Corby K, Fong S, Tagliaferri M, Quattrochi L, Cohen I, Shtivelman E, Christians U: Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study. Int J Cancer 2011, 129(12):2945-2957.
63. Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D et al: A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat 2010, 120(1):111-118.
64. Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, Hausted RP, Zheng J: Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev 2009, 18(4):331-341.
65. Chen V, Staub RE, Baggett S, Chimmani R, Tagliaferri M, Cohen I, Shtivelman E: Identification and analysis of the active phytochemicals from the anti-cancer botanical extract Bezielle. PLoS One 2012, 7(1):e30107.